165 related articles for article (PubMed ID: 29987552)
1. Positive effect of alendronate on bone turnover in ovariectomised rats' osteoporosis: comparison of transdermal lipid-based delivery with conventional oral administration.
Boche M; Pokharkar V
Drug Deliv Transl Res; 2018 Oct; 8(5):1078-1089. PubMed ID: 29987552
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
[TBL] [Abstract][Full Text] [Related]
3. Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
Bae J; Park JW
Int J Pharm; 2015 Mar; 480(1-2):37-47. PubMed ID: 25595570
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
Li B; Huang G; Ma Z; Qin S
Acta Biochim Pol; 2020 Jun; 67(2):173-179. PubMed ID: 32558528
[TBL] [Abstract][Full Text] [Related]
6. Alveolar bone dynamics in osteoporotic rats treated with raloxifene or alendronate: confocal microscopy analysis.
Ramalho-Ferreira G; Faverani LP; Grossi-Oliveira GA; Okamoto T; Okamoto R
J Biomed Opt; 2015 Mar; 20(3):038003. PubMed ID: 25813805
[TBL] [Abstract][Full Text] [Related]
7. [Development of a novel transdermal delivery system of alendronate, a nitrogen containing bisphosphonate, using a new type of hydrophilic patch and dissolving microneedle arrays].
Katsumi H
Yakugaku Zasshi; 2014; 134(3):427-31. PubMed ID: 24584024
[TBL] [Abstract][Full Text] [Related]
8. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone.
Viera-Negrón YE; Ruan WH; Winger JN; Hou X; Sharawy MM; Borke JL
J Oral Implantol; 2008; 34(2):76-82. PubMed ID: 18478902
[TBL] [Abstract][Full Text] [Related]
9. Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis.
Kong F; Jia B; Cui P; Wang D
Acta Biochim Pol; 2019 Dec; 66(4):463-467. PubMed ID: 31846272
[TBL] [Abstract][Full Text] [Related]
10. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats.
Zhao X; Wu ZX; Zhang Y; Yan YB; He Q; Cao PC; Lei W
J Ethnopharmacol; 2011 Oct; 137(3):1083-8. PubMed ID: 21782010
[TBL] [Abstract][Full Text] [Related]
11. Effects of alendronate on osteoporosis treatment and levels of related cytokines.
Liu CT; Yuan XJ; Gao GC
Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28362987
[TBL] [Abstract][Full Text] [Related]
12. Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate.
Villanueva-Martínez A; Hernández-Rizo L; Ganem-Rondero A
Int J Pharm; 2020 May; 582():119312. PubMed ID: 32278052
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
14. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
Nakamura Y; Hayashi K; Abu-Ali S; Naito M; Fotovati A
J Bone Joint Surg Am; 2008 Apr; 90(4):824-32. PubMed ID: 18381321
[TBL] [Abstract][Full Text] [Related]
15. Effect of Korean oriental medicine extract on bone mass as compared with alendronate in ovariectomized rats.
Lee JW; Jhee O; Yuan H; Kim T; Kim D; Lee M; Om A; Lee B; Park SK; Kang J
J Med Food; 2005; 8(3):369-76. PubMed ID: 16176149
[TBL] [Abstract][Full Text] [Related]
16. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
Bagi CM; Volberg M; Moalli M; Shen V; Olson E; Hanson N; Berryman E; Andresen CJ
Anat Rec (Hoboken); 2007 Aug; 290(8):1005-16. PubMed ID: 17610276
[TBL] [Abstract][Full Text] [Related]
17. Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis.
Takeuchi I; Kobayashi S; Hida Y; Makino K
Colloids Surf B Biointerfaces; 2017 Jul; 155():35-40. PubMed ID: 28391082
[TBL] [Abstract][Full Text] [Related]
18. Insights into Transdermal Drug Delivery: Approaches for Redressal of a Burgeoning Issue of Osteoporosis.
Zakir F; Kohli K; Ahmad FJ; Iqbal Z; Ahmad A
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1682-1695. PubMed ID: 32433014
[TBL] [Abstract][Full Text] [Related]
19. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.
Finkelstein JS; Leder BZ; Burnett SM; Wyland JJ; Lee H; de la Paz AV; Gibson K; Neer RM
J Clin Endocrinol Metab; 2006 Aug; 91(8):2882-7. PubMed ID: 16684825
[TBL] [Abstract][Full Text] [Related]
20. The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.
Vis M; Bultink IE; Dijkmans BA; Lems WF
Osteoporos Int; 2005 Nov; 16(11):1432-5. PubMed ID: 15883662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
